Factors Considered When Selecting Facilities for Covid Add-On Payments Audits in Clinical Diagnostic Labs

With the ongoing Covid-19 pandemic, clinical Diagnostic Labs play a crucial role in testing and diagnosing patients. The Office of Inspector General (OIG) has been closely monitoring these facilities and selecting them for audits related to COVID Add-On Payments. In this blog post, we will explore the factors that OIG considers when choosing facilities for these audits.

Factors Considered by OIG

1. Volume of Covid-19 Tests

One of the key factors that OIG considers when selecting facilities for COVID Add-On Payments audits is the volume of Covid-19 tests conducted by the lab. Facilities that have a high volume of tests are more likely to be audited to ensure that they are accurately billing for the services provided.

2. Geographic Location

The geographic location of the facility also plays a role in OIG's selection process. Labs located in areas with high rates of Covid-19 cases may be more closely scrutinized to ensure that they are following all guidelines and Regulations related to testing and billing.

3. Previous Compliance History

Facios with a history of non-compliance or previous violations may be more likely to be selected for audits. OIG wants to ensure that facilities are following all Regulations and guidelines set forth by the government, especially during a public health crisis like the Covid-19 pandemic.

4. Type of Tests Offered

The type of Covid-19 tests offered by the facility may also impact OIG's decision to audit. Facilities offering a wide range of tests or specialty tests may be subject to closer scrutiny to ensure that they are correctly billing for each test performed.

5. Use of Add-On Codes

OIG will also look at the facility's use of add-on codes when selecting facilities for audits. Add-on codes are used to indicate additional services provided during a patient encounter, and OIG wants to ensure that these codes are being used appropriately and accurately.

Audit Process

1. Notification

Facilities selected for audits will receive a notification from OIG informing them of the audit and providing details about the process. The facility will be required to submit documentation and information related to their Covid-19 testing practices and billing procedures.

2. Review of Documentation

OIG will review the documentation submitted by the facility to assess their compliance with all Regulations and guidelines related to Covid-19 testing and billing. This may include reviewing Test Results, billing records, and other relevant information.

3. On-Site Inspections

In some cases, OIG may conduct on-site inspections of the facility to further assess their compliance. During these inspections, OIG representatives will observe the facility's testing procedures, review documentation, and interview staff members to ensure that all protocols are being followed.

4. Findings and Recommendations

After completing the audit process, OIG will compile their findings and may make recommendations to the facility for improvement. These recommendations may include changes to billing procedures, training for staff members, or other actions to ensure compliance with Regulations.

Conclusion

In conclusion, OIG considers a variety of factors when selecting facilities for COVID Add-On Payments audits. By closely monitoring these facilities and ensuring compliance with Regulations, OIG helps to protect patients and ensure that clinical Diagnostic Labs are providing accurate and timely testing during the Covid-19 pandemic.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Jessica Turner, BS, CPT

Jessica Turner is a certified phlebotomist with a Bachelor of Science in Health Sciences from the University of California, Los Angeles. With 6 years of experience in both hospital and private practice settings, Jessica has developed a deep understanding of phlebotomy techniques, patient interaction, and the importance of precision in blood collection.

She is passionate about educating others on the critical role phlebotomists play in the healthcare system and regularly writes content focused on blood collection best practices, troubleshooting common issues, and understanding the latest trends in phlebotomy equipment. Jessica aims to share practical insights and tips to help phlebotomists enhance their skills and improve patient care.

Previous
Previous

Understanding the Appeal Process for Denied Clinical Pathology Reimbursements

Next
Next

Anticipating Changes in Billing and Reimbursement for Clinical Diagnostic Labs